Publication | Closed Access

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Protease InhibitorsLong-term Randomised TrialTreatment And PreventionMedicineAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyAntiviral DrugHivPharmacologyAids PathogenesisInitial Therapy